Coach Kyle

G.L.A. INVE$T RE$EARCH — Stock Spotlight-Cerebras Systems (NASDAQ: CBRS): The Pullback Is Noise. The Inference Demand Is the Signal.

Newsletter LibraryCompany researchAI infrastructure

Kyle’s original newsletter.

Cerebras Systems (NASDAQ: CBRS): The Pullback Is Noise. The Inference Demand Is the Signal.

Coach Kyle | October 12, 2026

Cerebras server-room artwork from the original edition

The Bottom Line

Cerebras is down more than 60% from its IPO-day high. It’s trading near $150, below its $185 IPO price, after a rough run of headlines: an OpenAI/Nvidia report, insider selling and a staggered unlock of insider shares. None of that changes the core story. The company just grew core revenue 103%, has $25.4 billion of contracted backlog, and Wall Street expects revenue to more than triple in 2027 as EPS turns solidly positive. ARK is buying the dip, and we like it here too.

G.L.A. View: BULLISH for long-term investors. Our call rests on next year’s earnings and revenue estimates and one simple fact: demand for fast inference still looks close to infinite.(Not individualized investment advice)

Snapshot (as of Oct. 12, 2026, intraday)

Server-room photograph from the original edition

Metric

Value

Share price

$150.56 (-8.29% today)

Market cap

$35.8B

52-week range

$148.50 – $386.34

IPO price (May 14, 2026)

$185.00

Cash and investments (Q2 2026 balance sheet)

$7.92B in cash and investments; $918.2M OpenAI working-capital loan outstanding

Analyst consensus

Strong Buy — 8 of 8 bullish

Average price target

$291 (~93% upside)

Next earnings

Q3 2026 — Nov. 11, after the close

Nasdaq celebration photograph from the original edition

What Cerebras Does

Cerebras builds the Wafer-Scale Engine, a single chip the size of a full silicon wafer. It puts compute and memory on one piece of silicon instead of linkingdozens of GPUs together. That design removes data-traffic bottlenecks and makes Cerebras the speed leader in AI inference, the moment a model actually answers you. Cerebras sells that speed two ways: as hardware (the CS-3 and the new CS-4) and as a fast-inference cloud service. The cloud service is now the faster-growing half of the business.

The customer list is getting deep. Per the Q2 call, it includes OpenAI, AWS, CrowdStrike, Figma, Cognition, Lovable, Block, AlphaSense and GSK.

Original Cerebras performance-comparison graphic

Growth & Sales: Verified Hypergrowth

Annual revenue

Year

Revenue

YoY Growth

FY2022

$24.6M

—

FY2023

$78.7M

+220%

FY2024

$290.3M

+269%

FY2025

$510.0M

+76%

FY2026E (consensus)

$887.1M

+74%

FY2027E (consensus)

$2.95B

+233%

Original Cerebras website screenshot

Revenue grew 20x from 2022 to 2025, and Cerebras booked a profit of $237.8 million in FY2025.

Q2 2026: the most recent quarter

  • Core revenue: $209.9M, up 103% year over year, a record.

  • Cloud and services revenue: $127.7M, up 287%. That’s nearly 4x, driven by demand for Cerebras Fast Inference.

  • Core hardware revenue: $82.1M, up 17%.

  • GAAP revenue: $180.1M, up 74.3%.

  • Core operating margin: -16%, versus -42% a year ago. That’s a 2,600-basis-point improvement in one year.

  • Remaining performance obligations (contracted backlog): $25.4 billion.

  • Cash, investments and restricted cash: more than $8.6 billion.

For context, $25.4 billion is about 29x this year’s expected revenue. Management says it doesn’t yet include any business from AWS or other hyperscalers.

Wafer-scale comparison infographic from the original edition

Earnings: Reading the Scorecard Correctly

Quarter

Revenue (actual vs. est.)

GAAP EPS (actual vs. est.)

1-day stock move

Q1 2026 (reported Jun. 23)

$193.4M vs. $181.2M — beat

-$0.04 vs. -$0.14 — beat

-19.6%

Q2 2026 (reported Aug. 12)

$180.1M vs. $190.6M — miss

-$2.98 vs. -$0.21 — miss

-11.8%

Q3 2026 (Nov. 11)

Est. $214.7M

Est. -$0.13 to -$0.15

—

AWS and Cerebras partnership graphic from the original edition

What actually happened in Q2: The GAAP loss of $450.5M (-$2.98 a share) came mostly from $377.0M of stock-based compensation tied to the IPO, a non-cash charge concentrated around the listing. On its core metrics, Cerebras beat its own guidance for revenue, gross margin and operating margin, and it raised full-year guidance.

Gross margin: Core gross margin dipped to 40.6% in Q2 from 46.5% in Q1. The reason: Cerebras is renting back its own systems from cloud customers so it can serve overflow inference demand sooner. The margin hit comes from too much demand, which is the good kind of problem. Management expects Q3 to be the low point (38%–40%). Margins should step up in Q4 as Cerebras-owned data centers come online, then trend toward a 60%+ target.

Executive and Nasdaq photograph from the original edition

Management guidance

Period

Guidance

Q3 2026 core revenue

$214M – $216M

FY2026 core revenue

$880M – $890M (raised)

FY2026 core gross margin

41% – 43% (raised)

FY2026 core operating margin

-19% to -17% (raised)

2027

Core revenue to grow more than 3x

Nasdaq celebration photograph from the original edition

Analyst Expectations & Estimates

Consensus estimates

FY2026E

FY2027E

Revenue

$887.1M

$2.95B

EBITDA

$37.5M

$1.20B

Gross profit

$372.2M

$1.43B

Diluted EPS

-$0.50

+$1.30

The quarterly ramp analysts are modeling

Quarter

Revenue Est.

EPS Est.

Q3 2026

$214.7M

-$0.15

Q4 2026

$274.4M

-$0.25

Q1 2027

$402.8M

-$0.08

Q2 2027

$567.0M

+$0.11

Q3 2027

$822.0M

+$0.47

Q4 2027

$1.12B

+$0.77

Q1 2028

$1.36B

+$0.93

Q2 2028

$1.68B

+$1.31

Source: Perplexity Finance — CBRS consensus estimates

Analysts see quarterly revenue rising from about $215 million today to about $1.68 billion by mid-2028, nearly 8x in under two years. They have EPS turning positive in Q2 2027 and free cash flow turning positive in early 2028.

GLAINVEST eagle and infinity artwork from the original edition

Price targets: every analyst is bullish

Firm

Rating

Price Target

Date

UBS

Buy

$330

Aug. 13

Citigroup

Buy

$320

Aug. 13

Mizuho

Outperform

$300

Aug. 13

Needham

Buy

$300

Aug. 19

Rosenblatt

Buy

$300

Aug. 19

Wedbush

Outperform

$290

Aug. 13

Morgan Stanley

Overweight

$279

Aug. 13

Freedom Capital

Upgraded to Buy

$209

Oct. 2

Consensus: Strong Buy, 8 of 8 bullish, average target $291, median $300. Source: Perplexity Finance — CBRS analyst research

Freedom Capital upgraded the stock in the middle of the selloff, calling the OpenAI fears overblown and pointing to strong inference demand. Barclays’ Tom O’Malley called the decline “overdone” and said Cerebras “remains the preferred provider limited by supply”.finance.yahoo+1

Valuation on next year’s numbers

At a $35.8B market cap, CBRS trades at about 12x 2027 consensus revenue. That’s for a company expected to grow revenue 233% next year with $25 billion already under contract. It’s also a far cry from the 54x–61x trailing-sales multiples quoted in the bearish headlines.

OpenAI and Cerebras partnership graphic from the original edition

The Restrictions: What’s Actually Weighing on the Stock

1. The IPO lockup: a staggered release, not a cliff

When Cerebras went public, insiders agreed to restrictions on when they could sell. Instead of one big unlock at 180 days, Cerebras is releasing those shares in 11 separate waves.

Date

Shares eligible for sale

After Q1 and Q2 earnings

~27.7M and ~36.4M

Aug. 19 – Sept. 16 (every two weeks)

~14.6M per wave

Sept. 30

~19.4M (about 8% of shares outstanding)

Oct. 14 (this Wednesday)

~19.4M

Oct. 28

~19.4M

Final release

All remaining — 2nd trading day after Q3 earnings or Nov. 9, whichever comes first

Cerebras product graphic from the original edition

The pattern is clear. The stock fell 8.87% on the Sept. 30 unlock day alone. Today’s 8% slide to a new post-IPO low comes two trading days before the next wave.

Why this is good news for long-term holders: The overhang has an end date. By about mid-November, every insider share will be free to trade. Selling pressure from unlocks is temporary and mechanical, and it says nothing about the business.

2. Insider selling under pre-set plans

CEO Andrew Feldman and CTO Sean Lie sold more than $240 million of shares between Aug. 20 and Sept. 25, under trading plans adopted shortly after the IPO (CNBC). COO Dhiraj Mallick sold 396,000 shares for about $80.8 million under a Rule 10b5-1 plan adopted June 30 (Gate News). These are pre-scheduled sales by founders who became billionaires on IPO day. They read as diversification, not a verdict on the company.

3. Export controls

Cerebras’ 10-Q notes that its products are subject to U.S. export controls and generally need licenses to ship to certain countries. This is a long-standing rule for every AI chipmaker, not a new restriction. Cerebras’ growth engine (OpenAI, AWS, U.S. enterprises and new data centers in places like Finland) sits largely in approved markets.investors.cerebras

How the Negative Headlines Hit the Stock

Verified timeline

Date

Headline

Stock reaction

Aug. 12

Q2 GAAP miss on IPO stock comp

-11.8% next day

Aug. 18

Supernova event (CS-4 launch)

-12.7% on the day

Sept. 29–30

SemiAnalysis says OpenAI’s GPT-6.1 Sol “Ultrafast” tier runs on Nvidia GPUs + 19.4M-share unlock

-8.9% on Sept. 30

Week ending Oct. 2

Insider sales + unlock + Nvidia report

-19.5% to $166.43, lowest close since IPO

Oct. 2 (evening)

Sam Altman: “Cerebras is a close partner”

+~3% after hours

Oct. 5

Rebound on Altman comments

+9% to $181.55

Oct. 12

Fresh low ahead of Oct. 14 unlock

-8.3% to ~$150

Sources: Yahoo Finance, TheStreet, CNBC, Perplexity Financecnbc+1

Our interpretation

The OpenAI scare was about one speed tier of one model. Neither OpenAI nor Cerebras confirmed which hardware runs it. Within days, OpenAI’s CEO stepped in personally to say “we have a deep engagement pushing on the frontiers of speed”. The 750-megawatt OpenAI agreement, worth more than $10 billion, runs through 2028 and hasn’t changed. Barclays’ read is that Cerebras is limited by supply, not demand, which matches what management said on the call.gate+2

This is a classic young-IPO pattern: a stock that reacts sharply to headlines, plus a steady stream of new shares hitting a small float. Headlines move the stock day to day. Earnings and backlog move it year to year.

ARK Is Still Buying the Pullback

Cathie Wood’s ARK has bought CBRS on nearly every major dip since the IPO, through the ARK Innovation ETF (ARKK) and the ARK Next Generation Internet ETF (ARKW).

Original ARK trading-activity screenshot

Date

Shares

Value

Context

Mid-May

149,176

~$46.4M

Right after the IPO

Jun. 23–24

124,949

~$28.3M

Around the Q1 report and 19.5% drop

Jun. 25

111,989

~$20.4M

Kept adding

Aug. 13

106,941

~$28.0M

Day after the Q2 selloff — largest single buy

Aug. 18

35,000

~$8.8M

Supernova-day drop

Aug. 20

—

~$14.5M

Continued accumulation

Aug. 25

93,290

~$17.3M

Funded partly by AMD sales

Sept. 8

32,561

~$6.5M

Swapped from Palantir

Oct. 2

117,758

~$20.0M

Bought at the post-IPO low close of $166.43

Sources: IndexBox, TradingView/GuruFocus, Investing.com, Yahoo Finance, GuruFocus, Yahoo Finance, Investing.com, TipRanks, Investing.comfinance.yahoo+8

That adds up to about $190 million of reported purchases in under five months, and the latest buy came on the exact day the stock hit its post-IPO low. ARK has repeatedly sold AMD and Palantir to fund these buys, a clear signal of where it sees the next leg of AI-chip upside. CBRS made up about 2.3% of ARKK as of Oct. 9.blog.arkinvesttrades

Wood’s thesis is simple: Cerebras doesn’t need to dethrone Nvidia. It just needs to own the speed slice of a massive market. ARK has also argued that Cerebras’ on-chip memory design could make expensive high-bandwidth memory less .

Wafer photograph from the original edition

Catalysts Ahead

  • Q3 earnings (Nov. 11): Guidance says gross margin should bottom here, setting up a “worst is behind us” quarter.

  • Final lockup release (around Nov. 9–13): The share-supply overhang ends.

  • Q4 2026: Launch of disaggregated inference with AMD Helios racks. More Cerebras-owned data centers come online, which should lift margins.

  • Q1 2027: Cerebras becomes available on Amazon Bedrock, giving it global enterprise reach.

  • Mid-2027: First revenue from additional hyperscalers.

  • Capacity: More than 600 MW of data center capacity secured, a pipeline “measured in gigawatts,” manufacturing capacity up more than 10x in 2026, and TSMC wafer supply in hand.

  • New capacity deals: A 165 MW data center with Compute Nordic in Finland.investors.cerebras

Original StocksToTrade article screenshot

G.L.A. View: Bullish

This section is our opinion.

We’re bullish on CBRS for long-term investors, and our conviction rests on next year’s numbers:

  1. Revenue is expected to more than triple. Consensus calls for $2.95 billion in 2027, up 233%, and management has guided to more than 3x growth as well.

  2. Earnings turn positive. Consensus EPS goes from -$0.50 this year to +$1.30 in 2027, with EBITDA above $1.2 billion. The heavy IPO stock-comp charges fade, and the operating leverage shows up.

  3. The backlog is real. $25.4 billion of contracted revenue gives us multi-year visibility, and that’s before AWS or any other hyperscaler is counted.

  4. Inference demand still looks close to infinite. Every chatbot answer, coding assist and AI-agent task runs on inference, around the clock. Feldman calls it “unbound demand for fast inference,” and the evidence backs him up. Cloud revenue nearly quadrupled, Cerebras is renting back its own systems just to keep up, and it’s limited by supply, not demand. When customers pay a premium for faster responses, speed becomes a moat.

  5. The price is right. CBRS trades at about 12x next year’s sales, every analyst is bullish, and the average target is near $291. The pullback gives long-term investors an entry point well below where ARK and other big buyers have been adding.

How we’d approach it: We expect volatility to stay high through the lockup schedule and Q3 earnings. For our long-term approach, that’s an opportunity, while the risks below still apply. Our approach is dollar-cost averaging through the Oct. 14 and Oct. 28 unlocks and into the Nov. 11 report, while the share overhang clears.

Cerebras tokens artwork from the original edition

Risks to Watch

We’re bullish, but we’re honest about the risks:

  • Customer concentration: OpenAI is the biggest piece of the backlog. A real shift of its workloads to Nvidia would matter.

  • Margins: Gross margin needs to climb from about 40% toward the 60%+ target, as promised.

  • Execution: Tripling revenue requires data centers, manufacturing and supply to scale on time.

  • Competition: Nvidia’s ecosystem, balance sheet and supply remain formidable.

  • Near-term supply: Two more unlocks of about 19.4M shares each, plus a final release, before mid-November.

Disclaimer: This report is for educational and informational purposes only and is not personalized investment advice. Data is as of October 12, 2026, and subject to change. Do your own research and consider your own risk tolerance before investing.

Kyle and eagle artwork from the original edition

G.L.A. INVE$T RE$EARCH | Coach Kyle

Balance-sheet clarification: cash and investments exclude restricted cash. The June 30 Form 10-Q reports the OpenAI working-capital loan and distinguishes quarterly from six-month stock compensation.

Original edition: Kyle’s Beehiiv newsletter. Author opinions, scenarios and dated estimates are retained; limited editorial clarifications do not verify every source claim.